SCHEMBL705995

SCHEMBL705995

[CH]=CC=CC=CC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1541787 1.00
SCHEMBL29274 0.87
SCHEMBL1541764 0.79
SCHEMBL1541765 0.79
SCHEMBL1541053 0.77
SCHEMBL1541054 0.77
SCHEMBL1677681 0.73
SCHEMBL1677682 0.73
SCHEMBL16034854 0.73 ALDH1A1 (0.32)
SCHEMBL979674 0.73 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461072-B2 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. (US) 2013-06-11 US claimed
US-7994086-B2 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-08-09 US claimed
US-20110092658-A1 Late Transition Metal Catalysts for Olefin Oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. 2011-04-21 US claimed
US-20050003955-A1 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. 2005-01-06 US claimed
US-20040138056-A1 Late transition metal catalysts for olefin oligomerizations EXXONMOBIL CHEMICAL PATENTS INC. 2004-07-15 US claimed
WO-2004037869-A2 LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-05-06 WO claimed
WO-2004037837-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-05-06 WO claimed
WO-2024123801-A1 COMPOUNDS FOR TREATING CANCER GENESIS THERAPEUTICS, INC. (US) 2024-06-13 WO disclosed
US-11744830-B2 Ameliorative agent for cytokine release syndrome and so on TORII PHARMACEUTICAL CO., LTD. (JP) 2023-09-05 US disclosed
US-20210128550-A1 AMELIORATIVE AGENT FOR CYTOKINE RELEASE SYNDROME AND SO ON TORII PHARMACEUTICAL CO., LTD. (JP) 2021-05-06 US disclosed
EP-3782625-A1 AGENT FOR IMPROVING CYTOKINE RELEASE SYNDROME, ETC TORII PHARMACEUTICAL CO., LTD. (JP) 2021-02-24 EP disclosed
CN-112105362-A Ameliorating agent for cytokine release syndrome and the like 鸟居药品株式会社 2020-12-18 CN disclosed
US-9465291-B2 Radiation-sensitive resin composition, polymer, compound, and method for producing compound JSR CORPORATION (JP) 2016-10-11 US disclosed
WO-1997001275-A1 COMBINATIONS OF INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1997-01-16 WO disclosed
US-5534654-A ANTITUMOR, ANTIINFLAMMATORY, INHIBITOR OF LYMPHOCYTE ADHESIVE FACTORS SHIONOGI & CO., LTD. (JP) 1996-07-09 US disclosed
US-5534536-A INHIBITORS OF THROMBOXANE A2 SYNTHETASE, 5-LIPOXYGENASE; SCAVENGERS OF ACTIVE OXYGEN SPECIES ONO PHARMACEUTICALS CO. LTD. (JP) 1996-07-09 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0640609-A1 Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species ONO PHARMACEUTICAL CO., LTD. (JP) 1995-03-01 EP disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed
EP-0570594-A1 HYDROXAMIC ACID DERIVATIVE BASED ON AROMATIC SULFONAMIDE SHIONOGI & CO., LTD. (JP) 1993-11-24 EP disclosed